CO-DIAGNOSTICS, INC. (CODX) Net margin 2017–2025
CO-DIAGNOSTICS, INC. (CODX) net profit margin by fiscal year — reported net income divided by reported revenue.
-7533.6%FY2025 · since FY2017: -90827.9% → -7533.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -7533.6% | -6572.3 pp |
| FY2024 | -961.4% | -442.7 pp |
| FY2023 | -518.7% | -477.1 pp |
| FY2022 | -41.6% | -79.1 pp |
| FY2021 | 37.5% | -19.5 pp |
| FY2020 | 57.0% | +2939.0 pp |
| FY2019 | -2882.0% | +12832.3 pp |
| FY2018 | -15714.3% | +75113.6 pp |
| FY2017 | -90827.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CODX financial trends
CODX RevenueCODX Net incomeCODX Gross profitCODX Gross marginCODX Operating incomeCODX Operating marginCODX Operating cash flowCODX Free cash flowCODX Capital expendituresCODX Return on equityCODX Stock buybacksCODX Dividends paidCODX Total assetsCODX Total liabilitiesCODX Shareholders’ equityCODX overview →